Pulp Friction

ProHub Comment

This case uses a straightforward market analysis approach to evaluate a new product launch decision. The candidate must calculate market sizing, conduct financial modeling across product lines, and assess whether the higher-margin antiviral segment justifies strategic pivot. The case emphasizes quantitative rigor combined with competitive positioning logic.

Estimated Time 15 minutes
Difficulty Easy
Source Wharton
50 / 100
Your client, TissueCo, is a large facial tissue manufacturer that sells to retailers. While the US facial tissue market suffered operational challenges due to Covid-19, the market is forecasted to recover and grow in 2021. While TissueCo has seen some improved numbers as they adapt to the pandemic, their profitability margin has fallen below their main competitors Kelly-Clark and Proxy and Gumbo. The CEO has invited you to help them out.

Clarifying Information

  1. The client is focused on US sales only
  2. TissueCo’s profitability margin dropped below its competitors before the COVID-19 outbreak but has further worsened after COVID-19
  3. TissueCo produces tissues that are standard, extra soft, and tissues with lotion
  4. There is no specific goal to improve profitability
  5. The expected CAGR in 2021 is 5.8%